Clearmind Closes $2.5M Charging Robotics Acquisition, Adds $1.5M Loan
CMND is trading near its 52-week low of $0.92 (13% above the low) on light trading volume (0.1× avg).
Summary
Clearmind finalized its 51% acquisition of EV wireless charging company Charging Robotics for $2.5M plus a $1.5M loan, and disclosed post-period share conversions and Nasdaq delisting risk.
Key Events · M&A and Partnerships · CMND
-
Charging Robotics Acquisition Closed
Definitive agreement to acquire 51% of Charging Robotics for $2.5M, with a $1.5M loan at 4% interest; closing occurred September 6, 2026.
-
Post-Period Convertible Note Conversions
CLA Investors converted $687,500 of Promissory Notes at $1.00/share, issuing 1,200,000 shares plus 192,159 abeyance shares; floor price amended to $1.00.
-
Warrant Exercise Price Reset
Conversions triggered warrant exercise price reduction to $1.00, increasing warrant shares issuable to 1,895,189.
-
Nasdaq Delisting Risk
MVLS of approximately $3.5M as of September 8, 2026, below the $5.0M Nasdaq threshold; delisting possible if SEC stay is lifted.
Analysis · CMND · Life Sciences
Clearmind converted its non-binding letter of intent into a definitive agreement, acquiring 51% of Charging Robotics for $2.5 million and extending a $1.5 million loan at 4% interest. The deal closed September 6, 2026. This is a major strategic pivot for a clinical-stage psychedelic company with a market cap near $1.5 million — the acquisition price alone exceeds the company's entire market value. The filing also reveals post-period convertible note conversions at $1.00 per share that added 1.2 million shares, and discloses that the company's MVLS of $3.5 million is below Nasdaq's $5 million threshold, creating delisting risk if the SEC stay is lifted.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 35.6% of the 1805 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CMND was trading at $1.04 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.5M. The 52-week trading range was $0.92 to $524.00. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.